to create the carbon skeleton lies in the reaction of a nor-
drimane anion with a protected polyhydroxybenzaldehyde;
this procedure was utilized by Banerjee et al. to prepare 2a,b,
which lack the chirality on C-9.9b
The construction of the C pyrane ring constitutes the
second phase in the complete synthetic sequence. The
stereoselectivity of this process determines the C-8 stereo-
chemistry, affording the natural (C8R-Me) compounds or
their epimers. Different methodologies have been utilized
to elaborate the pyrane ring. Electrophilic acid cyclization
of a drimenyl phenol, similar to compounds 20a,b, was first
utilized by Trammel.8a Our further studies of these processes
revealed a low degree of stereoselectivity, with the 8-epideriv-
ative found to be the major isomer,9a which is quite different
from the previously reported results.8a,10 Electrocyclization
of a conjugated tetraenone, similar to 19a,b, also allowed
the present authors to prepare 8-epipuupehedione (2b);9a the
same strategy was followed by Banerjee et al.9b The obtention
of natural 8-epimers, such as (+)-puupehenone (1a) and
related compounds, starting from drimenyl phenols, was
accomplished by the â-attack of the phenol hydroxyl group
on an R-seleno- or R-oxacyclopropane generated from the
carbon-carbon double bond; an R-selenocyclopropane was
utilized in our synthesis of (+)-puupehenone (1a).8b An
R-oxacyclopropane was the intermediate in our synthesis of
(+)-puupehedione (2a),9a this latter strategy also being
utilized by Tadano et al. in synthesizing 8 and 9.5 More
recently, Quideau et al. synthesized 1a, starting from an
8-hydroxydrimane with a suitable configuration on C-8, by
attack onto an oxidatively activated 1,2-dihydroxyphenyl
unit.8c
Figure 1. Examples of puupehenone (1a)-derived marine sponge
metabolites.
lipoxygenase,7a further heightening the interest in this class
of compounds.
The unique structural features and biological activities of
these compounds have prompted chemists to study their
synthesis.5,8-11 Most current approaches to this type of
compounds are based on a strategy involving the initial
formation of a suitably functionalized bicyclic terpenoid unit,
with the pyrane ring being generated late in the sequence.
Two strategies have been devised to elaborate the carbon
skeleton of these compounds. The first involves the reaction
of an aryllithium derived from a suitably protected phenolic
unit with an acyclic (farnesane derivative) or bicyclic
(drimane derivative) electrophile.5,9-11 The drimane synthon,
an 8-oxygenated aldehyde8b-c,9a or an 8,9-epoxyaldehyde5
or an unsaturated aldehyde,10,11 possesses the correct chirality
for three of the four stereogenic centers, i.e., C-5, C-9, and
C-10, presented by these compounds. The alternative strategy
Following our research into the synthesis of puupehenone-
related compounds based on homochiral synthons obtained
from natural sources, we are interested in developing a new
route to this type of compounds utilizing alternative synthons
and cyclizing reagents. We focused on 15-oxopuupehenol
(4a), an antitumor and antimalarial metabolite, which has
not been synthesized hitherto. The 15-oxopuupehenol deriva-
tive previously reported, the configuration of which on C-8
was assigned on the basis of the absence of NOE effect,
was actually the non-natural 8-epimer10 as is shown in the
present paper. Our planned synthesis of 4a is based on the
benzylic oxidation of a tetracyclic advanced intermediate,
which will result from a diastereoselective cyclization of a
drimenylphenol precursor, itself derived from a condensation
between a suitably protected trihydroxyaryllithium with
drimenal (15).12
(7) (a) Amagata, T.; Whitman, S.; Johnson, T. A.; Stessman, C. C.; Loo,
C. P.; Lobkovsky, E.; Clardy, J.; Crews, P.; Holman, T. R. J. Nat. Prod.
2003, 6, 230-235. (b) Castro, M. E.; Gonzalez-Iriarte, M.; Barrero, A. F.;
Salvador-Tormo, N.; Mun˜oz-Chapuli, R.; Medina, M. A.; Quesada, A. R.
Int. J. Cancer 2004, 110, 31-38.
(8) Synthesis of 1a,b in racemic form: (a) Trammel, G. L. Tetrahedron
Lett. 1978, 1525-1528. Synthesis of 1a in optically active form: (b)
Barrero, A. F.; Alvarez-Manzaneda, E. J.; Chahboun, R. Tetrahedron Lett.
1997, 38, 2325-2328. (c) Quideau, S.; Lebon, M.; Lamidey, A.-M. Org.
Lett. 2002, 22, 3975-3978.
(9) Synthesis of 2a,b in optically active form: (a) Barrero, A. F.; Alvarez-
Manzaneda, E. J.; Chahboun, R.; Corte´s, M.; Armstrong, V. Tetrahedron
1999, 55, 15181-15208. Synthesis of 2b in optically active form: (b) Maiti,
S.; Sengupta, S.; Giri, C.; Achari, B.; Banerjee, A. K. Tetrahedron Lett.
2001, 42, 2389-2391. (c) Armstrong, V.; Barrero, A. F.; Alvarez-
Manzaneda, E. J.; Corte´s, M.; Sepu´lveda, B. J. Nat. Prod. 2003, 66, 1382-
1383. (d) Ishibashi, H.; Ishihara, K.; Yamamoto, H. J. Am. Chem. Soc.
2004, 126, 11122-11123.
The drimane synthon 15 is easily prepared by the oxidation
of (-)-drimenol (14).13,14 Scheme 1 shows a new and
efficient synthesis of 15 from (-)-sclareol (10), the key step
being regioselective dehydration of diol 13, by treatment with
DEAD and PPh3 in benzene; this finding resulted from our
investigation into the synthesis of carbonyl compounds under
the Mitsunobu conditions.15 The drimane precursor is the
(10) Synthesis in optically active form of the methylenedioxyderivative
of 4b: Arjona, O.; Garranzo, M.; Maluego, J.; Maroto, E.; Plumet, J.; Sa´ez,
B. Tetrahedron Lett. 1997, 38, 7249-7252.
(11) Synthesis in racemic form of monoterpene analogues of 1 and 2:
Barrero, A. F.; Alvarez-Manzaneda, E. J.; Herrador, M. M.; Valdivia, M.
V.; Chahboun, R. Tetrahedron Lett. 1998, 39, 2425-2428.
(12) Scher, J. M.; Speakman, J.-B.; Zapp, J.; Becker, H. Phytochemistry
2004, 65, 2583-2588.
(13) Isolated from the bark of D. winteri. See: Appel, H. H.; Brooks, J.
W.; Overton, K. H. J. Chem. Soc. 1959, 3322-3332.
1478
Org. Lett., Vol. 7, No. 8, 2005